October 29th, 2024
SIS Medical hosted successfully a scientific symposium with more than 170 attendees about “The role of OPN NC in calcified coronary lesions” during the TCT congress 2024 in Washington DC, USA.
The faculty, led by Dr. Emmanouil Brilakis (Minneapolis, USA), and Dr. Florim Cuculi (Luzern, Switzerland) presented latest research and clinical cases targeting luminal gain in calcified lesions.
All speakers, Dr. Darshan Doshi (Boston, USA), Dr. Nachiket Patel (Mesa, USA), Dr. Stéphane Rinfret (Gainesville, USA), Dr. Natalia Pinilla (Hamilton, Canada), pointed out key success factors for an effective and safe calcium plaque modification:
(1) Using intravascular imaging to size the lumen gain,
(2) Defining the lesion strategy and having a device toolbox available for any intravascular adjustments,
(3) Seeking for PCI optimization whether it is after DES implantation with stent expansion or as lesion preparation for DCB.
OPN NC super-high pressure TWIN-wall balloon was summarized as an effective and safe device for in-stent restenosis, serve calcified lesions and stent expansion.
October 25th, 2024
SIS Medical is a proud sponsor of Academic Satellite Symposium during the TCT2024.
This event is an amazing opportunity to connect with physicians and innovators for a cutting-edge session, networking and more.
SIS Medical Satellite Symposium
📅 October 28th
10:30 a.m.
See full agenda and register: https://lnkd.in/eqTrgtXZ
This program is a live, in-person event and will take place at the meeting venue, the Walter E. Washington Convention Center (Washington DC, USA)!
September 5th, 2024:
SIS Medical was happy to sponsor the Swiss CTO&CHIP summit this year again. We greatly value the course directors Dr. Gregor Leibundgut & Dr. Daniel Weilenmann and all participant’s creativity and enthusiasm in addition to the amazing scientific program.
Seeing and reuniting with so many motivated, passionate and skilled CTO operators who committed their work to improving patient’s lives was a great pleasure!
We look forward to enjoying the new edition in 2025!
September 1st, 2024:
We proudly announce the appointment of Thomas Kraft, PhD. as Chief Executive Officer, effective September 2024.
Dr. Kraft will lead the company’s growth in the upcoming phase and elevate its expansion to the next international level.
Having worked in the MedTech sector for more than 20+ years on a global scale, Thomas brings to SIS Medical a track record of achieving both strategic growth and operational excellence. His background equips him uniquely to lead SIS Medical into its next successful chapter.
